CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Surflay's WhisperSense technology enhances drug discovery and biomarker identification by enabling real-time kinetic analysis of biological interactions in complex environments. This innovation significantly reduces sample preparation time and improves accuracy in selecting drugs and diagnostics, with applications in b…
The latest industry research shows that about 90 percent of drugs that reach clinical stage fail due to incorrect selection methods.
The same applies to diagnostic markers. A crucial failure source is the imperfect identification and characterisation of biological interaction analytics in the early stages of drug discovery and biomarker identification.
Surflay's innovation addresses this challenge.
The company developed the unique WhisperSense technology based on the physical effect of whisperin…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
